Additionally, NANOG expression is negatively correlated with postoperative survival in patients with lung and ovarian cancer [19, 24], and increased NANOG expression in human prostate cancer tissues is correlated with an increased Gleason score, which is an indicator of poor prognosis [22, 28]. This evidence concerns the gene NANOG and ovarian cancer.